People · Operator

Brian L. Coley

Named in public records as an officer, director or promoter · active 2017–2017 · Healthtech

1
Companies
1
Filings
$34.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Eyas Medical Imaging, Inc.HealthtechSeries A$34.5M$73.8M2017
Operator network

Brian L. Coley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Michael Venerable · 9 companies · 1 sharedMichael VenerableBrian Coley · 1 companies · 1 sharedBrian ColeyBrian Matthew Coley · 1 companies · 1 sharedBrian Matthew Col…Charles Dumoulin · 1 companies · 1 sharedCharles DumoulinEmma Matthew Off · 1 companies · 1 sharedEmma Matthew OffJoland L. Rutgers · 1 companies · 1 sharedJoland L. RutgersJoland Rutgers · 1 companies · 1 sharedJoland RutgersMichael Begg · 1 companies · 1 sharedMichael BeggMichael L. Venerable · 1 companies · 1 sharedMichael L. Venera…Michael Matthew Begg · 1 companies · 1 sharedMichael Matthew B…Michael Matthew Venerable · 1 companies · 1 sharedMichael Matthew V…Rich Wilmot · 1 companies · 1 sharedRich WilmotRobert L. Kwolyk · 1 companies · 1 sharedRobert L. KwolykRobert Matthew Storer · 1 companies · 1 sharedRobert Matthew St…Eyas Medical Imaging, Inc. · $34.5M raisedEyas Medical Imaging,…Brian L. ColeyBC
Brian L. Coley Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Brian L. Coley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Michael Venerable19
Michael Matthew Begg11
Robert Matthew Storer11
Brian Matthew Coley11
Emma Matthew Off11
Michael Matthew Venerable11
Michael Begg11
Brian Coley11
Rich Wilmot11
Charles Dumoulin11
Joland Rutgers11
Robert L. Kwolyk11
Michael L. Venerable11
Joland L. Rutgers11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.